Akihito Tanaka Daijo Inaguma Yu Watanabe Eri Ito Naoki Kamegai Hiroya Shimogushi Hibiki Shinjo Kiyomi Koike Yasuhiro Otsuka Asami Takeda
10.2169/internalmedicine.56.7958
Intern Med
2017;56(12):1531-1535.
evolocumab familial hypercholesterolemia low-density lipoprotein apheresis
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28626179/
Antibodies, Monoclonal / therapeutic use Anticholesteremic Agents / therapeutic use Blood Component Removal / methods Hyperlipoproteinemia Type II / therapy
Antibodies, Monoclonal / therapeutic use Anticholesteremic Agents / therapeutic use Blood Component Removal / methods Hyperlipoproteinemia Type II / therapy Case Reports Aged Angina Pectoris / complications Antibodies, Monoclonal, Humanized Cholesterol, LDL / blood Female Humans Hyperlipoproteinemia Type II / complications Hyperlipoproteinemia Type II / drug therapy Lipoproteins, LDL / blood Male Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Anticholesteremic Agents Cholesterol, LDL Lipoproteins, LDL evolocumab
PMC5505909
28626179
Two Patients with Familial Hypercholesterolemia Who Were Successfully Weaned from Low-density Lipoprotein Apheresis after Treatment with Evolocumab
2017